In Brief Meydan et al. report that programmed ribosomal frameshifting in the E. coli copper transporter gene copA produces a copper chaperone. The frameshiftstimulating mRNA elements are also present in copA genes of many bacteria and the human homolog ATP7B.
INTRODUCTION
Copper homeostasis is critical for organisms from all domains of life. Due to the ability of copper ions to switch between two oxidation states, Cu(I) and Cu(II), copper serves as an essential cofactor for enzymes that participate in key processes including electron transport and the oxidative stress response (Arredondo and Nú ñ ez, 2005) . In excess, however, copper ions are extremely toxic for the cell, likely because of their role in generating reactive oxygen species (Rensing and Grass, 2003) . Disruption of copper homeostasis has been linked to human maladies, e.g., Menkes, Wilson, and Parkinson diseases, as well as cystic fibrosis (Bull et al., 1993; Percival et al., 1999; Tó rsdó ttir et al., 1999; Vulpe et al., 1993) . Sophisticated systems have evolved to maintain copper homeostasis in bacterial and eukaryotic cells (Fan and Rosen, 2002; Outten and O'Halloran, 2001) , in which the central role belongs to copper-translocating ATPases responsible for export of excess copper ions from the cell (Fan and Rosen, 2002; Migocka, 2015) .
The operation of copper transporters in bacteria often relies on the assistance of metal chaperones (e.g., CopZ in Bacillus subtilis and Enterococcus hirae). These small soluble proteins facilitate trafficking of copper ions to the transporters and their regulators (Banci et al., 2001; Cobine et al., 1999; Palumaa, 2013) . Curiously, while the Cu(I) efflux transporter CopA operates in Escherichia coli, a gene for the CopZ-like diffusible chaperone was not identified in its genome (Fan et al., 2001; Rensing et al., 2000) . A recent study demonstrated that the copper hypersensitivity caused by the artificial truncation of the N-terminal metal binding domain 1 (MBD1) of the E. coli CopA transporter could be compensated in trans by expression of the B. subtilis CopZ chaperone (Drees et al., 2015) . Intriguingly, the same beneficial effect was achieved by ectopic expression of the E. coli CopA MBD1 itself, indicating that the N-terminal segment of CopA could potentially provide the copper chaperone function in E. coli. However, in contrast to the diffusible metal chaperones found in many organisms (Jordan et al., 2001; Palumaa, 2013) , the putative copper chaperone of E. coli, as a part of the CopA protein, has to operate as an integral part of the membrane transporter. Such an arrangement should inevitably restrict the ability of the chaperone to scavenge copper ions from cytosolic locations and deliver them to the membrane-embedded efflux pump.
Several serendipitous observations hinted that expression of the E. coli copA gene might deviate from the conventional pathway. Gel analysis of small proteins expressed in E. coli revealed the presence of a short polypeptide with an estimated molecular weight (MW) of $6.5 kDa, whose tryptic peptides matched those of the CopA MBD1 (Wasinger and HumpherySmith, 1998 ). Although such a protein could hypothetically be generated via proteolytic degradation of the full-size transporter, no evidence for specific cleavage of CopA by cellular proteases has been reported. Even more puzzling, recent ribosome profiling examination of protein synthesis in the E. coli strain MG1655 indicated that the number of translating ribosomes abruptly drops in the vicinity of the 70th codon of the copA gene (Li et al., 2014) . A similar unexplained decrease in ribosome density within copA could also be seen in other ribosome profiling datasets collected from various E. coli strains and under different growth conditions (Balakrishnan et al., 2014; Elgamal et al., 2014; Guo et al., 2014; Kannan et al., 2014; Li et al., 2014; Mohammad et al., 2016; Oh et al., 2011) . This unique pattern of distribution of ribosome progression along the gene suggested that expression of copA might be a subject of idiosyncratic regulation.
One of the mechanisms exploited by cells for expanding the spectrum of proteins expressed from a limited number of genomic open reading frames (ORFs) is translational recoding (Baranov et al., 2002) . This term refers to a variety of scenarios in which interpretation of the genetic information deviates from the straightforward single-frame codon-by-codon translation of mRNA by the ribosomes. Among other options, recoding may involve programmed ribosomal frameshifting (PRF), a forward or backward slippage of the ribosome to an alternative reading frame within the ORF. PRF conceptually resembles spontaneous frameshift errors, although its frequency is usually significantly higher and could be subjected to specific regulation (Farabaugh and Bjö rk, 1999; Kurland, 1992) . In order to achieve high efficiency of recoding, particular structural features are embedded in mRNA, including PRF-prone ''slippery sequences'' (SSs), upstream or downstream stimulatory RNA secondary structures, or the presence of internal Shine-Dalgarno-like sequences (Caliskan et al., 2015; Farabaugh, 1996) . Two core E. coli genes are known to be regulated by PRF. Expression of release factor 2 (RF2) from the prfB gene is controlled by +1 PRF. The PRF frequency depends on the efficiency of translation termination at the premature in-frame stop codon, which in turn requires RF2 activity. Only the full-size release factor, generated as the result of PRF, carries physiologically meaningful cellular function, whereas the truncated, prematurely terminated peptide seems to play no functional role (Craigen and Caskey, 1986) . In contrast to prfB, the À1 PRF in the dnaX gene generates two functional polypeptides corresponding to individual subunits of the same enzyme, DNA polymerase III (Blinkowa and Walker, 1990; Flower and McHenry, 1990; Tsuchihashi and Kornberg, 1990) . More recently, it has been shown that À1 PRF in the gene csoS2 of CO 2 -fixating bacteria leads to production of two isoforms of the CsoS2 protein involved in the biogenesis of a-carboxisome. However, the functionality of one of the isoforms still remains unconfirmed (Chaijarasphong et al., 2016) .
Here, we show that the copA gene in E. coli encodes two proteins, likely with related but distinct functions. Translation of the entire gene generates a membrane copper transporter CopA, while À1 PRF leading to premature termination results in synthesis of the 70 aa-long copper chaperone CopA(Z). A highly efficient À1 PRF, stimulated by an SS and specific elements encoded within the mRNA and nascent polypeptide, controls expression of the two polypeptides from a single ORF. The same SS and a similar downstream mRNA structure are present in the human ATP7B gene, which codes for the copper transporter homolog of bacterial CopA, and whose functional defects are implicated in Wilson disease (Bull et al., 1993; Gupta and Lutsenko, 2012) . The utilization of PRF by the copper transporter genes illuminates the role of recoding in maintaining the homeostasis of an essential metal in the cell.
RESULTS
In Vivo Expression of the copA Gene Results in the Formation of the 70 aa-Long CopA(Z) Ribosome profiling revealed an abrupt decrease of ribosome density in the vicinity of the 70th codon of the E. coli copA gene (Balakrishnan et al., 2014; Elgamal et al., 2014; Guo et al., 2014; Kannan et al., 2014; Li et al., 2014; Mohammad et al., 2016; Oh et al., 2011) (Figure 1A ). We hypothesized that this unique pattern of copA translation could reflect the specific expression of an approximately 70 aa residues-long truncated CopA protein via an as yet undefined mechanism. This putative polypeptide would encompass the entire MBD1 of the CopA transporter ( Figure 1A ) and thus would closely correspond to the N-terminal segment of CopA proposed to serve as a transporter-linked copper chaperone in E. coli (Drees et al., 2015) . In order to explore whether the N-terminal segment of CopA is indeed synthesized in the cell as an individual polypeptide, we used the copA-containing ASKA library plasmid (Kitagawa et al., 2005) to express the N-terminally His 6 -tagged CopA (we will refer to this plasmid as pCopA). Introduction of pCopA in the DcopA E. coli strain BW25113 (Baba et al., 2006) led to the appearance of not only the full-size CopA transporter, but also of a polypeptide that migrated in an SDS gel as a $10-12 kDa protein ( Figures 1B and 2B ). The size of this shorter product, as estimated from its electrophoretic mobility, closely matched the predicted MW for the His 6 -tagged MBD1 of CopA ($9 kDa). To determine the precise size of the expressed truncated CopA polypeptide, which we named CopA(Z), we purified it using an Ni 2+ affinity column ( Figure 1B ) and determined its exact MW by mass spectrometry ( Figure 1C ). The experimentally determined MW of the expressed His 6 -tagged CopA(Z) was 9,323 Da. This value was in reasonable agreement with the profiling results, where the ribosomal density dropped immediately after the 70th codon; the predicted MW of the polypeptide encoded by the first 70 codons of the copA gene would be 9,337 Da. Thus, the results of the mass spectrometry analysis suggested that a diffusible 70 aa-long CopA(Z) protein encompassing MBD1 is expressed from the copA gene alongside the fullsize 834 aa-long CopA, a transmembrane metal transporter. Such a scenario would resolve the mystery of the missing copper chaperone in E. coli. However, the mechanism of generation of CopA(Z), as well as the origin of the difference of 14 Da between its predicted and experimentally determined MWs ( Figure 1C ), remained puzzling.
PRF Resulting in Premature Termination of Translation Is Responsible for the Production of CopA(Z)
We explored the reason for the discrepancy between the predicted and experimentally determined MW of CopA(Z), hoping that it held the clue to the mechanism of its generation. The molecular mass difference between the estimated and experimental CopA(Z) molecular mass could be accounted for by the replacement of the CopA(Z) C-terminal alanine, encoded in the copA 70th codon, with glycine ( Figure 1C ). Such a change could be brought about by a single nucleotide substitution in the 70th codon, converting it from GCT to GGT (Gly). However, neither the chromosomal gene of the parental BW25113 strain nor the gene present in the pCopA plasmid deviated from the reported copA sequence. We also considered the possibility of RNA editing, where the sequence of the 70th codon would be altered at the mRNA level, but sequencing of the RT-PCR-amplified copA mRNA showed no difference from the DNA sequence.
Having excluded nucleotide sequence alteration as a source of the CopA(Z) C-terminal amino acid change, we explored other scenarios that might lead to the synthesis of a truncated protein with an aberrant amino acid sequence. Close inspection of the copA sequence showed that the GCU 70 codon overlaps with a GGC (Gly) codon in the À1 reading frame, which, in this alternative frame, is immediately followed by a stop codon (Figure 2A) . Furthermore, the triplet GGC appears within the sequence 5 0 -CCCAAAGGC-3 0 (Figure 2A) , which matches the general pattern X-XXY-YYZ that is classified as an SS because it has been reported to promote efficient À1 PRF (Jacks et al., 1988a; Sharma et al., 2014) . These observations, combined with our experimental data, offer a straightforward explanation for the generation of the CopA(Z) polypeptide ending with a Gly residue. First, ribosomes translating the copA ORF undergo À1 PRF within the SS and incorporate a Gly residue instead of an Ala as the 70th amino acid of the polypeptide. Translation then terminates at the following stop codon (Figure 2A ) and a short protein with the molecular mass of 9,323 Da, precisely matching the experimentally determined mass of the in vivo-expressed His 6 -CopA(Z), is produced ( Figures 1B  and 1C ).
To verify this scenario, we mutated the SS in the plasmid pCopA from 5 0 -CAC-CCA-AAG-GC-3 0 to 5 0 -CAT-CCT-AAG-GC-3 0 (pCopA-mSS) ( Figure 2B ). The two introduced mutations preserve the amino acid sequence encoded by the wild-type (WT) copA but disrupt the SS and, hence, were expected to prevent the translating ribosome from slipping into the À1 frame. Indeed, western blot analysis showed that cellular expression of His 6 -CopA(Z) (but not of His 6 -CopA) was abrogated by the SS mutations ( Figure 2B ). In addition, we were able to reproduce the PRF event of copA in the E. coli S30 transcription-translation cell-free system. For this, we generated a DNA template containing the first 94 codons of the gene, which included the SS region (copA 1-282 template in Figure 2C ). In vitro expression of this template resulted in appearance of the encoded full-length protein (CopA 1-94 ) and of the 70 aa-long CopA(Z), readily visualized by an SDS gel ( Figure 2C ). Consistent with our in vivo observations, production of CopA(Z) in the cell-free system was abrogated when the SS sequence was altered ( Figure 2C ). These experimental results provided strong support for the hypothesis that CopA(Z) is generated in vivo and in vitro from the copA gene via SS-promoted À1 PRF.
Secondary Structure of the copA mRNA Stimulates -1 PRF The precipitous drop in ribosome density after the 70th codon of the copA gene observed in profiling experiments ( Figure 1A ) suggests that a large fraction of the ribosomes that initiate translation at the start codon of the gene could shift to the À1 frame and prematurely terminate after translating 70 codons. Because the mere presence of a 7 nt-long SS is insufficient to account for PRF (Giedroc et al., 2000) , we hypothesized that additional -affinity chromatography. The short protein with the electrophoretic mobility approximately corresponding to the His 6 -tagged MBD1 of CopA, which we named CopA(Z), is indicated by arrowheads. (C) Top-down mass spectrometric analysis of the purified His 6 -tagged CopA(Z). The deconvoluted monoisotopic mass of 9,323.61 Da is consistent with the predicted mass of CopA(Z) (9, 337.60 Da) , where the C-terminal Ala, encoded in the 70th codon of copA, is replaced with Gly. The spectrum shows multiply charged species of the intact protein; for reference, the peak corresponding to the charge 10+ is indicated by an arrow. The amino acid sequence of His 6 -tagged CopA(Z) is shown below and the C-terminal Gly is boxed. elements residing either in the copA mRNA and/or the encoded CopA peptide could stimulate recoding.
The À1 PRF is often promoted by mRNA structural elements that hinder the forward movement of the ribosome along the transcript, thereby stimulating the backward slippage of the ribosome-tRNA complex (Plant et al., 2003) . Computational modeling of the possible folding of the copA mRNA segment following the À1 PRF site predicted the formation of a stemloop structure, which may be a part of a stable pseudoknot (PK) (DG = À19.7 kcal/mole) ( Figure 3A) . Furthermore, the location of the first stem (S1) of the predicted PK relative to the SS is compatible with its stimulatory role in promoting efficient À1 PRF (Giedroc and Cornish, 2009) .
We tested the contribution of the downstream mRNA segment containing the putative PK to PRF efficiency by analyzing in vitro expression of CopA(Z) from a series of 3 0 truncated copA templates ( Figure 3B ). The longest template, copA 1-312 , contained the first 104 codons of copA (the region encompassing the SS and the entire PK), followed by an engineered stop codon that would direct translation termination in the 0 frame. Expression of this construct yielded both the full-length encoded protein (104 aa long) and the shorter (70 aa long) CopA(Z) ( Figure 3C , lane ''1-312''). The À1 PRF efficiency, calculated from the relative intensities of the major products bands, was approximately 45% ( Figure 3D ). The efficiency of À1 PRF gradually diminished in the progressively 3 0 truncated templates in which the second (S2) PK stem (constructs copA 1-261 and copA 1-243 ) or both PK stems (construct copA 1-222 ) were eliminated ( Figure 3B ). CopA(Z) production was largely abrogated when only 15 nucleotides downstream of SS were present in the construct ( Figures  3C and 3D) . Collectively, the results of these experiments indicate that the mRNA segment downstream of SS likely adopts a specific secondary structure fold and is essential for promoting highly efficient À1 PRF that mediates the generation of CopA(Z).
The CopA Nascent Peptide Modulates -1 PRF Nascent peptide-ribosome interactions often play an important role in regulation of translation (Ito and Chiba, 2013) and can influence certain recoding events (Chen et al., 2015; Gupta et al., 2013; Samatova et al., 2014; Weiss et al., 1990; Yordanova et al., 2015) . We considered the possibility that the CopA nascent chain might affect the frequency of À1 PRF and hence play a role in controlling the relative expression of CopA(Z) and CopA proteins from the same gene. In order to test the effect of the CopA nascent peptide on PRF, we introduced two sets of compensatory single-nucleotide indel mutations within the template copA . The first set of mutations (construct copA 1-312 -NP1; Figures 4A and S1, available online) altered the sequence of CopA amino acid residues 4-29 located outside the ribosomal exit tunnel when the ribosome reaches the PRF site (Figures 4A and S1) . With the second set of mutations, the sequence of the CopA segment 31-67, which resides in the exit tunnel of the frameshifting ribosome, was altered (construct copA 1-312 -NP2). The integrity of the SS and PK regions was preserved in both mutants. Because the amino acid composition of either of the mutant proteins is different from that of the WT CopA(Z), control templates were prepared (constructs CopA(Z) M -NP1 and CopA(Z) M -NP2 in Figure S1 ) to generate the corresponding mutant CopA(Z) proteins to serve as electrophoretic mobility markers. In vitro À1 PRF efficiencies on the mutant copA 1-312 -NP1 and copA 1-312 -NP2 constructs were calculated from the intensities of the gel bands corresponding to the truncated and full-size products encoded in the 104 codons of the WT and mutant templates. Changing the sequence of the N-terminal segment of CopA (the copA 1-312 -NP1 construct) had little effect on À1 PRF frequency in vitro, which remained comparable to the WT level ( Figures 4B and 4C ). However, when the inner-tunnel segment of the CopA nascent chain was altered, PRF efficiency dropped nearly 2-fold ( Figures 4B and 4C ). We further tested whether the contribution of the nascent peptide to À1 PRF in copA is manifested in vivo. For this, we introduced the WT or mutant versions of the copA 3-294 sequence into the dual luciferase reporter plasmid pEK4 (Grentzmann et al., 1998; Kramer and Farabaugh, 2007) (Figure 4D ). In this plasmid, the downstream firefly luciferase (Fluc) coding sequence is in the À1 frame relative to the preceding Renilla luciferase (Rluc) ORF. A À1 PRF is required to generate functional Fluc, whereas Rluc serves as an internal control for the 0-frame translation. Expression of the reporter carrying the WT copA 3-294 sequence inserted after the Rluc ORF resulted in $32% À1 PRF efficiency (for the purpose of the subsequent comparison, we took the frequency of WT À1 PRF as 100%; Figure 4E) . As expected, À1 PRF was abrogated when the SS was disrupted (mSS reporter in Figures 4D and 4E) . Consistent with the results obtained in vitro, altering the copA codons 31-67 in pEK4 to generate the construct NP2 ( Figures S1 and 4D ) reduced the À1 PRF efficiency by $40% ( Figure 4E ). We therefore concluded that the CopA nascent chain residing inside the ribosomal exit tunnel modulates the efficiency of À1 PRF during translation of the copA gene both in vitro and in vivo.
Diffusible CopA(Z) Generated via -1 PRF Facilitates Cell Survival at Elevated Concentrations of Copper Our experimental data argue that the long-missing enigmatic copper chaperone of E. coli is generated via À1 PRF during translation of the copA gene. If high-frequency PRF within the copA gene is the result of an evolutionary selection rather than a genetic aberrance, production of the diffusible CopA(Z) protein should facilitate the maintenance of copper ion homeostasis. The recent work of L€ ubben and coworkers has shown that the expression of CopA with an N-terminal truncation, i.e., a version of the transporter protein lacking the MBD1 domain, increased the sensitivity of E. coli to copper (Drees et al., 2015) . This defect could be rescued by the ectopic expression of the CopA N-terminal protein fragment encompassing MBD1 (Drees et al., 2015) , whose identity closely matched the naturally produced CopA(Z) that we observed in our experiments (Figures 1 and  2 ). Although the result described by Drees et al. hinted that the MBD1 of CopA could possibly function as a metal chaperone, the experimental set-up did not precisely match the true cellular scenario, where CopA(Z) is co-expressed from the copA gene via À1 PRF alongside the full-size CopA transporter. To test whether CopA(Z) contributes to copper tolerance when expressed from the intact copA gene, we compared survival of E. coli during exposure to copper, when production of the fullsize CopA was unaffected but generation of CopA(Z) was either allowed (WT) or prevented by the SS mutations. Two synonymous codon mutations, which disrupted the SS sequence by changing it from 5 0 -CAC 201 -CCA 204 -AAG-GC-3 0 (WT) to 5 0 -CAT 201 -CCT 204 -AAG-GC-3 0 (mSS mutant) but did not change the encoded amino acid sequence, were introduced in the copA gene of the BW25113 chromosome. We then mixed equal numbers of WT and mSS cells and passaged the culture for several generations at a mildly toxic concentration of CuSO 4 (4 mM). Changes in the mSS/WT cell ratio were monitored by PCR amplifying the copA gene from the genomic DNA of the mixed culture and analyzing the Sanger sequencing chromatogram peaks corresponding to the gene's positions 201 and 204, those that differ in the WT and mSS cells ( Figures 5A-5C ). After 50 generations of growth in the presence of 4 mM CuSO 4 , most of the cells in the co-culture carried the WT copA, whereas the mSS cells had practically disappeared (Figures 5C and 5D) . Thus, the production of diffusible CopA(Z) via À1 PRF enables cell survival in the presence of toxic concentrations of copper. This result argues that the presence of PRF signal in the copA gene is an evolutionarily selected trait. This conclusion is further supported by the observation that the mRNA structural elements promoting À1 PRF (SS and a predicted PK) are present at the edge of the MBD1-encoding copA segment in a wide range of bacterial species ( Figures S2  and S3 ), indicating that co-expression of the copper ion transporter and its chaperone from the same gene could be advantageous for many bacterial species.
A -1 PRF Signature Could Be Identified in the Human Homolog of the Bacterial copA Gene The transporter protein ATP7B in human cells is homologous to the bacterial CopA and, similar to CopA, catalyzes the efflux of copper ions (Gupta and Lutsenko, 2012) . ATP7B carries six MBDs that are involved in copper ion trafficking (Barry et al., 2010; Cater et al., 2004) . Interestingly, the heptanucleotide 5 0 -CCCAAAG-3 0 , identical to the SS of E. coli copA, is present between the MBD2-and MBD3-coding segments of ATP7B (Figure 6A) . Furthermore, the SS in the human gene is immediately followed by an mRNA sequence predicted to form a stable I-type PK (Theis et al., 2008 ) (DG = À27 kcal/mole) ( Figure 6B ). The arrangement of these elements, which are known to stimulate recoding, suggests that À1 PRF may take place during translation of the ATP7B mRNA. Because a stop codon is present in the À1 frame at a short distance after the À1 PRF signal ( Figures  6A and 6B) , the putative recoding event could result in production of a truncated protein composed of MBD1 and MBD2 of ATP7B. To assess whether the combination of SS and predicted PK of ATP7B could promote À1 PRF, the sequence encompassing these two elements was introduced into a eukaryotic dual luciferase reporter construct (Grentzmann et al., 1998) ( Figure 6C ) and tested in HEK293T cells. Measuring the relative activities of Rluc and Fluc revealed that the putative recoding elements from the ATP7B gene promoted À1 PRF with 12% efficiency ( Figure 6D ), a level comparable to that mediated by the wellcharacterized HIV À1 PRF signal (Jacks et al., 1988b) . When a termination codon was introduced prior to the ATP7B recoding elements (PTC in Figure 6C ) or when a stop codon was inserted at the beginning of the À1 frame Fluc ORF (OOF in Figure 6C ), the Fluc expression was abrogated, ensuring that expression of Fluc is indeed driven by PRF that takes place within the ATP7B-derived segment of the reporter. A similar arrangement of the SS followed by a putative downstream PK and a stop codon in À1 frame is found in ATP7B homologs of higher primates and some other mammals ( Figure S4 ), an observation that opens the possibility that in these organisms, similar to bacteria, a À1 PRF-based recoding may be involved in generating two ATP7B-encoded proteins with related but distinct functions in copper management.
DISCUSSION
While several cases of PRF are known in bacteria (Atkins et al., 2016) , there is essentially only one well-substantiated example where À1 PRF leads to the generation of two functional proteins from one gene (dnaX) (Blinkowa and Walker, 1990) . Our finding that À1 PRF in the E. coli gene copA directs synthesis of two functional proteins illuminates a possible broader penetrance of this distinctive mechanism of protein coding and gene regulation. Several lines of evidence support the view that production of the short CopA(Z) polypeptide along with the full-size CopA from the same gene is a result of evolutionary selection for improved cell fitness, rather than a spontaneous non-consequential genetic aberrance. First, the location of the À1 PRF site is ideal for generating a protein nearly precisely corresponding to the functional MBD1 domain, which, as it has been shown, retains its metal ion binding properties (Drees et al., 2015) . Second, if spontaneous appearance of a generic heptameric SS (XXXYYYZ) could be a relatively frequent scenario, its co-occurrence with the mRNA and nascent peptide elements that stimulate PRF should be an extremely rare event. In the case of À1 PRF in copA, both the mRNA structure and the specific sequence of the CopA nascent chain contribute to the highly efficient PRF and hence stimulate production of CopA(Z). Third, the conservation of the SS in the copA genes of a range of bacterial species, together with the presence of a characteristic downstream mRNA structure at a proper distance from the SS to efficiently promote À1 PRF, argues that co-production of CopA and its putative diffusible chaperone from one gene is evolutionarily beneficial. The final, but possibly the strongest, argument in favor of the functional significance of the copA À1 PRF is the fact that abolishing PRF, and thus CopA(Z) production, by SS-disrupting mutations results in reduced cell tolerance to elevated concentrations of copper. Although exploring the direct function of CopA(Z) in the maintenance of copper homeostasis was beyond the scope of our study, previous reports strongly argue that this protein plays the role of the ''missing'' copper chaperone in E. coli. A recent study has demonstrated that ectopically expressed MBD1 of CopA can bind copper ions with high affinity and transfer them to the transporter-both characteristics of a metal ion chaperone (Drees et al., 2015) . However, because there was no clear evidence that the MBD1 could be naturally produced as an independent protein in E. coli, it remained unknown how MBD1 could efficiently scavenge copper ions from the cytoplasm while remaining an integral part of the membrane-embedded transporter. Our finding that CopA MBD1 in fact exists in two forms, transporter bound and diffusible, solves this conundrum. If this assertion is correct and CopA(Z) is indeed a true ''free-floating'' copper chaperone, this would make PRF in copA a unique recoding event because it leads to the generation of two proteins independently functioning in the same biochemical pathway. This scenario is distinct from À1 PRF in dnaX (Tsuchihashi and Kornberg, 1990 ) and possibly csoS2 (Chaijarasphong et al., 2016) , where PRF produces two polypeptides of a multi-subunit complex that function as a single enzyme.
One of the intriguing questions about copA expression is whether the production of CopA(Z) via À1 PRF occurs with invariable frequency in every growth condition or if, alternatively, the efficiency of PRF and the ratio of CopA(Z) to CopA are subject to regulation. It is conceivable that the formation and/or stability of the downstream mRNA secondary structure could be sensitive to the copper ion concentrations (Furukawa et al., 2015) , or that the PRF stimulatory effect of the nascent peptide in the ribosomal exit tunnel could be modulated by the metal. Further research is needed to answer these questions.
While the co-occurrence of SS and downstream PK in the copA genes of a number of bacterial species strongly suggests that co-expression of a transporter and a putative chaperone is a beneficial trait, the discovery of a similar arrangement of PRF-stimulating elements in the human ATP7B gene was unexpected. Until recently, all of the examples of À1 PRF reported for mammalian genomes originated from retroviral insertions (Clark et al., 2007; Manktelow et al., 2005; Wills et al., 2006) . However, a recent report revealed the first examples of ''true'' non-retroviral À1 PRF signals, suggesting that this molecular mechanism is more commonly used than previously thought (Belew et al., 2014) . Furthermore, while the SS is present at a short distance after the MBD2-coding segment of the ATP7B gene in genomes of several mammals ( Figure S4) , it is not found in many other eukaryotes. At this point we do not have clear evidence whether À1 PRF indeed occurs in the human ATP7B gene or results in the production of a truncated protein with chaperone or other auxiliary functions in maintaining copper homeostasis. However, the fact that the ATP7B-derived element directs efficient in vivo À1 PRF in the luciferase reporter is compatible with such a scenario. Mutations in the ATP7B gene resulting in impairment of copper excretion have been linked to Wilson disease (Bull et al., 1993) . It is worthwhile exploring whether some of the mutations, which cause the disease, could disrupt production of not only the ATP7B-encoded transporter protein, but also of the functional shorter polypeptide.
EXPERIMENTAL PROCEDURES Strains and Plasmids
The ASKA collection plasmid that we named pCopA (Table S2) carries the E. coli copA gene encoding the N-terminally His 6 -tagged CopA protein (Kitagawa et al., 2005) . The pCopA plasmid was introduced into the Keio collection E. coli strain JW0473-3 lacking chromosomal copA (copA::kan) (Baba et al., 2006) . The point mutations that generated the PRF-deficient copA variant in the pCopA-mSS plasmid were engineered using the QuikChange Lightning Multi-Site-Directed Mutagenesis kit (Agilent Technologies) and primer #1 (all primer sequences are listed in Table S1 ). The PRF-deficient variant of the chromosomal copA (mSS), in which the SS sequence 5 0 -CAC 201 -CCA 204 -AAG-GC-3 0 was mutated to 5 0 -CAT 201 -CCT 204 -AAG-GC-3 0 , was engineered in the BW25113 strain by homologous recombination using the pKOV plasmid (Link et al., 1997) . Two PCR products were generated: primers #11 and #12 were used to generate the first one, using plasmid pCopA-mSS as the template, and primers #13 and #14 were used to prepare the second product using genomic DNA of E. coli BW25113 as the template. Both PCR products, which contain overlapping sequences, were introduced by Gibson assembly into the pKOV plasmid cut with NotI and BamHI restriction enzymes. The resulting pKOV-mSS plasmid, carrying the sequence starting 800 nucleotides upstream and ending 1,207 nucleotides downstream of the start codon of the mutant copA gene, was transformed into BW25113 cells by electroporation. The transformants were plated onto Luria-Bertani (LB)/agar supplemented with 30 mg/mL chloramphenicol, and plates were incubated overnight at 42 C to induce integration of the plasmid into the chromosome. Several colonies were resuspended in 1 mL LB and dilutions were plated on LB agar plates supplemented with 5% (w/v) sucrose to induce resolution of the vector. After overnight incubation of the plates at 37 C, the loss of the vector plasmid was confirmed by replica plating, which showed the sensitivity of the cells to chloramphenicol. The resulting mSS was used in the competition experiments. The bacterial dual luciferase reporter plasmids were prepared on the basis of the pEK4 plasmid (Grentzmann et al., 1998; Kramer and Farabaugh, 2007) . To engineer the reporter plasmids with the copA À1 PRF element, three PCR fragments (DLR1, DLR2, and DLR3) were generated using plasmid pCopA as the template. The PCR products DLR1 (primers #15 and #16), DLR2 (primers #17 and #18), and DLR3 (primers #19 and #20), which contain overlapping sequences, were introduced by Gibson assembly into pEK4 cut with SalI/SacI to generate pEK4-copA 3-294 -WT. The resulting plasmid contained codons 2-98 of the WT copA inserted in frame after the first (Rluc) gene in pEK4. Similarly, pEK4-copA 3-294 -mSS was assembled from the same DLR1, DLR3 fragments, and the DLR2-mSS PCR product, which was amplified from the pCopA-mSS plasmid using primers #21 and #22. Plasmid pEK4-copA 3-294 -NP2 was assembled from the DLR3 fragment combined with DLR1-NP2 and DLR2-NP2 amplified from the synthetic copA 1-312 -NP2 gBlock (Table S1 ) using primers #15 and #16 or primers #23 and #24, respectively. In all three reporter plasmids, the copA sequence carried the deletion of nucleotide T210, located downstream of the entire À1 PRF signal, introduced to eliminate an in-frame stop codon, and allowed for translation of the Fluc ORF upon À1 PRF. Control plasmid pEK4-copA 3-294 -C, which was used for normalization of the relative levels of Rluc and Fluc expression in the absence of À1 PRF, contained Fluc and Rluc in the 0 frame, whereas the copA À1 PRF was disabled by the mSS mutations. This plasmid was obtained by introducing the DLR-C fragment, amplified from pCopA-mSS using primers #25 and #26, into the SalI/SacI cut pEK4 plasmid. The 0-frame version of pEK4-copA 3-294 -NP2-C control plasmid was constructed using fragments DLR1-NP2, DLR2-NP2-C (primers #27 and #28), and DLR3-NP2-C (primers #19 and #29), which were introduced into SalI/SacI cut pEK4 by Gibson assembly. The Gibson assembly reactions were transformed into E. coli JM109 cells. Plasmids with the desired sequences were then introduced into BW25113 host cells in order to carry out the dual luciferase reporter assays.
Overexpression of copA and Purification of CopA(Z) The E. coli DcopA cells (JW0473-3) carrying the pCopA plasmid were grown at 37 C in LB medium supplemented with kanamycin (50 mg/mL) and chloramphenicol (30 mg/mL). Upon reaching an A 600 of 0.6, cultures were induced with 0.1 mM isopropyl-b-D-1-thiogalactopyranoside (IPTG) and incubation continued for 3 hr. Cells were collected by centrifugation at 4 C, resuspended in buffer (20 mM Tris [pH 8.0], 300 mM NaCl, 30 mM imidazole) supplemented with 13 Halt Protease Inhibitor (Life Technologies), and lysed using a French Press at 16,000 psi. The lysate was clarified by centrifugation at 15,000 rpm (rotor JA-25.50) for 1 hr at 4 C and then filtered through a 0.2 mm cellulose acetate filter. The lysate was passed through a HisTrap HP column (GE) using an AKTA/Unicorn FPLC system (GE). Bound protein was eluted using a linear 30-300 mM imidazole gradient. Fractions in which the CopA(Z) protein was detected, as assessed by SDS gel electrophoresis (4%-20% TGX [Bio-Rad]), were pooled together and subjected to an additional round of purification on the HisTrap HPcolumn, this time using a stepwise 30-300 mM imidazole elution. The purified protein was dialyzed using Spectra/Por membrane (MWCO 3,500) against 10 mM ammonium acetate (pH 8.0) for 3 hr at 4
C. The recovered sample was concentrated in Amicon concentrator (MWCO 3,000). Concentration of the isolated protein was measured using the bicinchoninic acid assay (BCA) kit (Thermo Scientific) and its purity was confirmed by gel electrophoresis and silver staining (Chevallet et al., 2006) .
Mass Spectrometry Analysis
Purified protein ($100 mg) was precipitated with cold acetone to remove salts and resuspended in 4% SDS prior to the addition of GELFREE loading buffer. Separation was performed as described (Tran and Doucette, 2009 ) using a 10% gel on a commercial GELFREE 8100 system (Expedeon). The fraction containing CopA(Z) was isolated and SDS was removed using the methanol-chloroform-water method (Wessel and Fl€ ugge, 1984) . After SDS removal, proteins were resuspended in 40 mL solvent A (94.9% H 2 O, 5% acetonitrile, and 0.1% formic acid) and 5 mL were injected onto a trap column (150 mm ID 3 3 cm) coupled with a nanobore analytical column (75 mm ID 3 15 cm). The trap and analytical column were packed with polymeric reverse-phase media (5 mm, 1,000 Å pore size) (PLRP-S, Phenomenex). Samples were separated using a linear gradient of solvent A and solvent B (4.9% water, 95% acetonitrile, and 0.1% formic acid) over 60 min. Mass spectrometry data were obtained on an Orbitrap Elite mass spectrometer (Thermo Scientific) fitted with a custom nanospray ionization source. Intact mass spectrometry data were obtained at a resolving power of 120,000 (m/z 400). The top 2 m/z species were isolated within the Velos ion trap and fragmented using higher-energy collisional dissociation (HCD). Data were analyzed with ProSightPC against a custom CopA database.
Western Blotting
Five micrograms of total protein from lysates of uninduced or IPTG-induced BW25113 cells transformed with pCopA or pCopA-mSS were loaded on a 4%-20% polyacrylamide-SDS gel (TGX, Bio-Rad). Resolved proteins were transferred to a PVDF membrane (Bio-Rad) by electroblotting (Bio-Rad Trans-Blot SD Semi-Dry Transfer Cell, 10 min at 25 V). The membrane was blocked with 3% BSA (Sigma-Aldrich) in TBST buffer (10 mM Tris-Cl [pH 7.4], 150 mM NaCl, and 0.1% Tween-20) and probed with 6x-His Epitope Tag Antibody HRP conjugate (Thermo Scientific) at 1:2,000 dilution. The blots were developed using Clarity Western ECL substrate (BioRad) and visualized using FluorChem R System (Protein Simple).
Growth Competition Experiments
Overnight cultures of WT (BW25113) and mSS cells were diluted 1:100 in fresh LB and grown to mid-log phase (A 600 $0.5). The cell densities in both cultures were adjusted to the same value, and equal volumes of the WT and mSS cultures were mixed. The 1:1 cell mixture (starting culture) was diluted to A 600 of 0.001 and grown overnight in LB without or with the addition of 4 mM CuSO 4 . Five microliters of the overnight culture were diluted into 5 mL LB with or without 4 mM CuSO 4 . Cultures were diluted 1,000-fold upon reaching saturation for a total of five passages. Aliquots from every passage were used to isolate genomic DNA, and the SS region of copA was PCR amplified using primers #6 and #11 (Table S1 ) and the following PCR conditions: 94 C, 2 min; followed by 34 cycles, 94 C, 2 min; 52 C, 30 s; 68 C, 15 s, and final extension at 68 C for 2 min. The PCR fragments were subjected to Sanger sequencing using primer #6. The ratio of the mSS to WT cells was estimated by quantifying and then averaging the heights of the sequencing chromatogram peaks corresponding to copA residues 201 (C for WT, T for mSS) and 204 (C for WT, T for mSS).
In Vitro Measurement of -1 PRF Efficiency Coupled in vitro transcription-translation reactions in the E. coli lysate were performed using an S30 transcription-translation system for linear DNA (Promega). DNA templates (0.6 pmol) were PCR amplified from either E. coli BW25113 genomic DNA or the plasmid pCopA-mSS (using primers #2 to #10 for both), or from synthetic gBlocks (Table S1 ). The resulting templates carrying the gene segment of interest controlled by the Ptrc promoter were translated in 5 mL reactions containing 2 mCi [
35 S]-L-methionine (specific activity 1,175 Ci/ mmol) (MP Biomedicals). Reactions were incubated at 37 C for 30 min and translation products were precipitated with 8 vol cold acetone. After the recovery of the pellet by centrifugation, proteins were resolved on 16.5% Tricine-SDS polyacrylamide gels (Sch€ agger and von Jagow, 1987) . The gels were dried, exposed to a phosphorimager screen, and visualized with a Typhoon scanner (GE). Protein bands corresponding to CopA(Z) (the À1 PRF product) and the relevant truncated CopA reference (originated from 0-frame translation) were quantified using the ImageJ software (https://imagej.nih.gov/ij/). PRF efficiency was estimated as a ratio of the density of the CopA(Z) band to the combined density of CopA(Z) and full-protein gel bands.
Identification of -1 PRF Elements in Different Species
Bacterial orthologs of copA (E. coli) were retrieved from OrtholugeDB (Waterhouse et al., 2013) . Coordinates of MBDs of CopA were determined by HMMSEARCH and Pfam model PF00403 (Finn et al., 2014; Wistrand and Sonnhammer, 2005) . For prediction of À1 PRF elements analogous to À1 PRF signal in the E. coli copA, the bacterial copA genes encoding two sequential MBDs were selected. The gene segments separating two MBDs were scanned for the presence of À1 PRF signals (À1 frame SS, nearby À1 frame stop codon, and a downstream mRNA structure) using KnotInFrame (Theis et al., 2008) . For the genes with the interdomain-coding segment shorter than 50 nt, the last 50 nt of the MBD1 coding sequence and the first 150 nt of the MBD2 coding sequence were also included in the KnotInFrame search. After removing redundancy for the strains of the same species, the predicted À1 PRF is found in 35 copA genes belonging primarily to the proteobacteria branch of the bacterial phylogenetic tree. Maximum likelihood (ML) tree for 35 CopA sequences was computed (Huerta-Cepas et al., 2016) , and the resultant tree ( Figure S2 ) was decorated with phyla/class-level taxonomy information. The structure of copA mRNA was initially modeled by using IPknot (Sato et al., 2011) and KnotInFrame (Theis et al., 2008) . The Simulfold program (Meyer and Mikló s, 2007) was used to generate the final consensus structure and the covariational mutations (Figures 3 and S3) . Aligned cDNA sequences of human ATP7B and its orthologs ( Figure S4 ) were retrieved from Ensembl (release 85) (Aken et al., 2016) . The prediction of ATP7B mRNA downstream structure was based on KnotInFrame (Theis et al., 2008) by submitting downstream the 100 nt-long sequence as input.
Bacterial Dual Luciferase Reporter Assay
The E. coli BW25113 cells carrying the derivatives of the pEK4 plasmid were grown at 37 C in 5 mL LB medium supplemented with 50 mg/mL ampicillin. Upon reaching A 600 of 0.5, cells were collected by centrifugation at 4 C and then resuspended in 200 mL lysis buffer (1 mg/mL lysozyme, 10 mM Tris-HCl [pH 8.0], and 1 mM EDTA). The lysates were prepared by freezing-thawing as previously described (de Wet et al., 1985) . Five microliters of the extracts were used for Fluc and Rluc activities using the Dual-Luciferase Reporter Assay System (Promega). Luminescence was measured in 96-well plates in Top Count NXT (Perkin Elmer). The PRF efficiency (rPRF) was calculated using the equation rPRF = (Fluc test /Rluc test )/(Fluc control /Rluc control ) (Grentzmann et al., 1998) , where test plasmids were pEK4-copA 3-294 , pEK4-copA 3-294 -mSS, and pEK4-copA 3-294 -NP2, and the control plasmids were pEK4-copA 3-294 -C and pEK4-copA 3-294 -NP2-C (Table S2) . Experimental replicates were performed using lysates prepared from bacterial cultures grown from three independent colonies.
Dual Luciferase Assay for -1 PRF in Human Cells
The ATP7B-derived sequence indicated in Figure 6B , acquired as a gBlock (Integrated DNA Technologies) (Table S1 , #32-34), was cloned into SalI/SacI-cut p2luci plasmid so that a À1 PRF event would direct ribosomes elongating through the upstream Rluc ORF into the downstream Fluc ORF. Two additional mutants, one harboring a UAA termination codon in the 0 frame immediately 5 0 of the ATP7B-derived sequence, and the other with a termination codon in the À1 frame 3 0 of the ATP7B-derived sequence, were also constructed on the basis of this vector. Plasmid constructs verified by DNA sequencing were transfected into HEK293T human cells. The dual luciferase assays were performed as previously described and the resulting data reflecting relative activity of the expressed Fluc and Rluc proteins were subjected to statistical analyses (Jacobs and Dinman, 2004) . Assays were repeated at least five times until statistical significance was achieved. The nucleotide sequences of the DNA templates used for in vitro translation and the amino acid sequences of the proteins encoded in 0 frame. The copA 1-312 template carries the wt copA sequence except for insertion of two stop codons (UAA) after codon 104. The wt amino acid sequence (residues in orange) was changed in the copA 1-312 -NP1 (amino acids shown in dark blue) and copA 1-312 -NP2 (residues in light blue) templates by introducing compensatory indel mutations (indicated by the arrows). Additional mutations introduced to avoid the appearance of premature stop codons in the mutant constructs are indicated with bold and underlined characters. Notice that none of the changes in the templates disrupted the integrity of the CCCAAAG slippery sequence (boxed). The cartoons, which represent ribosomes positioned at the copA slippery sequence, illustrate the portion of the CopA nascent chain that has been altered. Also shown are the sequences of the marker templates copA(Z) M , copA(Z) M -NP1, and copA(Z) M -NP2, in which the relevant CopA(Z) polypeptides, used as markers for the gel electrophoresis, are encoded in the 0 frame. Phylogenetic tree of bacterial species whose copA genes contain an SS heptamer followed by a nearby -1 frame stop codon. The colored vertical bars indicate the phylum of each bacterial species. The criteria applied for the selection of the species included in the tree is described in STAR methods. The stems S1 and S2 of the predicted pseudoknot downstream from the slippery sequence (boxed) in the copA gene of different bacteria are indicated by green and blue arches, respectively. Note that the covariation of residues within the S1 and S2 sequences is consistent with the folding of mRNA into the pseudoknot structure.
SUPPLEMENTAL INFORMATION
ATGTCACAAACTATCGACCTGACCCTGGACGGCCTGTCCTGCGGTCACTGCGTTAAACGCGTGAAAGAA AGTCTTGAACAGCGTCCGGATGTTGAGCAGGCGGATGTGTCTATCACTGAAGCGCACGTTACCGGGACT GCCAGTGCAGAACAGCTGATCGAAACCATCAAACAAGCGGGTTATGACGCATCTGTAAGCCACCCAAAG GCTAAACCGCTGGCGGAGTCATCAATCCCGTCGGAAGCACTGACAGCGGTTTCTGAGGCGCTTCCGGCA GCGACCGCCGATGACGATGACAGCCAGCAGTTGCTGTAATAA M S Q T I D L T L D G L S C G H C V K R V K E S L E Q R P D V E Q A D V S I T E A H V T G T A S A E Q L I E T I K Q A G Y D A S V S H P K A K P L A E S S I P S E A L T A V S E A L P A A T A D D D D S Q Q L L * * copA 1-312 ATGTCACAAACTATCGACCTGACCCTGGACGGCCTGTCCTGCGGTCACTGCGTTAAACGCGTGAAAGAA AGTCTTGAACAGCGTCCGGATGTTGAGCAGGCGGATGTGTCTATCACTGAAGCGCACGTTACCGGGACT GCCAGTGCAGAACAGCTGATCGAAACCATCAAACAAGCGGGTTATGACGCATCTGTAAGCCATCCGAAG GGTTAATAA G * * copA(Z) M copA 1-312 -NP1 M S Q T I D L T L D G L S C G H C V K R V K E S L E Q R P D V E Q A D V S I T E A H V T G T A S A E Q L I E T I K Q A G Y D A S V S H P K copA(Z) M -NP1 ATGTCACAACTATCGACCAGACCCTGGACGGCCTGTCCTGCGGTCACTGCGTTAAACGCGAGAAAGAAA GTCTTGAACAGCGTCCGGATGGTTGAGCAGGCGGATGTGTCTATCACTGAAGCGCACGTTACCGGGACT GCCAGTGCAGAACAGCTGATCGAAACCATCAAACAAGCGGGTTATGACGCATCTGTAAGCCACCCAAAG GCTAAACCGCTGGCGGAGTCATCAATCCCGTCGGAAGCACTGACAGCGGTTTCTGAGGCGCTTCCGGCA GCGACCGCCGATGACGATGACAGCCAGCAGTTGCTGTAATAA M S Q L S T R P W T A C P A V T A L N A R K K V L N S V R M V E Q A D V S I T E A H V T G T A S A E Q L I E T I K Q A G Y D A S V S H P K A K P L A E S S I P S E A L T A V S E A L P A A T A D D D D S Q Q L L * * ATGTCACAACTATCGACCAGACCCTGGACGGCCTGTCCTGCGGTCACTGCGTTAAACGCGAGAAAGAAA GTCTTGAACAGCGTCCGGATGGTTGAGCAGGCGGATGTGTCTATCACTGAAGCGCACGTTACCGGGACT GCCAGTGCAGAACAGCTGATCGAAACCATCAAACAAGCGGGTTATGACGCATCTGTAAGCCATCCGAAG GGTTAATAA G * * M S Q L S T R P W T A C P A V T A L N A R K K V L N S V R M V E Q A D V S I T E A H V T G T A S A E Q L I E T I K Q A G Y D A S V S H P K copA 1-312 -NP2 ATGTCACAAACTATCGACCTGACCCTGGACGGCCTGTCCTGCGGTCACTGCGTTAAACGCGTGAAAGAA AGTCTTGAACAGCGTCCGGATGTGAGCAGGCGGATGTGTCTATCACTGAAGCGCACGTTACCGGGACTG CCAGTGCAGAACAGCAGATCGAAACCATCAAACAAGCGGGTTATGACGCATCTGTATGCCAACCCAAAG GCTAAACCGCTGGCGGAGTCATCAATCCCGTCGGAAGCACTGACAGCGGTTTCTGAGGCGCTTCCGGCA GCGACCGCCGATGACGATGACAGCCAGCAGTTGCTGTAATAA M S Q T I D L T L D G L S C G H C V K R V K E S L E Q R P D V S R R M C L S L K R T L P G L P V Q N S R S K P S N K R V M T H L Y A N P K A K P L A E S S I P S E A L T A V S E A L P A A T A D D D D S Q Q L L * * copA(Z) M -NP2 ATGTCACAAACTATCGACCTGACCCTGGACGGCCTGTCCTGCGGTCACTGCGTTAAACGCGTGAAAGAA AGTCTTGAACAGCGTCCGGATGTGAGCAGGCGGATGTGTCTATCACTGAAGCGCACGTTACCGGGACTG CCAGTGCAGAACAGCAGATCGAAACCATCAAACAAGCGGGTTATGACGCATCTGTATGCCAATCCGAAG GGTTAATAA G * * M S Q T I D L T L D G L S C G H C V K R V K E S L E Q R P D V S R R M C L S L K R T L P G L P V Q N S R S K P S N K R V M
C C C C C A A A G C C U G A C C C G U U G A C A G A C U C A G A C A U U C A G C C G G A A G C G C U G A C A G C G G C A A A A A C C G A G C U U C C G G C A C A A C

Erwinia tasmaniensis
CG C C C A A A G A C U G A C C C G C U G A C A G A C U C A G A C A U U C A G C C G G A A G C G C U G A C A G C G G C C A C C A G C G A G C U U C C G G C G C A A C
Erwinia amylovora Erwinia billingiae U A C C C A A A G G C U A A A C C G C U G A C A G A G U C A U C A A U C C C G U C G G A A G C A C U G G C A G C G G U U C C U C A U G A G C U U C C G G U A G C G A C A C C C A A A G G C U A A A C C G C U G A C G G A G U C A U C A A U C C C G U C G G A A G C A C U G G C A G C G G U U C C U C A U G A G C U U C C G G U A G C G A
Salmonella enterica serovar Typhi.
C A C C C A A A G G C U A A A C C G C U G G C G G A G U C A U C A A U C C C G U C G G A A G C G C U G G C A G C G G U C C C U G A U G A G C U U C C G G C A G C C G
Citrobacter rodentium C A C C C A A A G G C U A A A C C G C U G G C A G A A U C A U C A A U C C C G U C G G A A G C A C U G A C A G C G G C C A C U C C U G A G C U U C C G G C A G C C C
Klebsiella pneumoniae C A C C C A A A G G C U A A A C C G C U G G C A G A A U C A U C A A U C C C G U C G G A A G C A C U G A C A G C G G C C A C U C C U G A G C U U C C G G C A G C C C
Enterobacter aerogenes C A C C C A A A G G C U A A A C C G C U G G C A G A A U C A U C A A U C C C G C C G G A A G C G C U G A C A G C G G C C A C C U C U G A G C U U C C G G C A G C C C
Klebsiella oxytoca C A C C C A A A G G C U A A C C C G C U G A C A G A G U C A U C A A C C C C G U C G G A A G C A C U G A C A G C G G C G C A A U G U G A G C U U C C G G C A G C G G
Cronobacter sakazakii
C A C C C A A A G G C U A A C C C G C U G A C A G A G U C A U C A A U C C C G U C G G A A G C G C U G A C A G C G G A C A C U C C U G A G C U U C C G G C A G C C A
Enterobacter sp. 638
C A C C C A A A G G C U A A A C C G C U G G C A G A G U C A U C A U C C C C G U C G G A A G C A C U G A C A G C G G C C A C U C C U G A G C U U C C G G U A G C U G
Enterobacter cloacae C A C C C A A A G G C U A A A C C G C U G G C G G A G U C A U C A A U C C C G U C G G A A G C A C U G A C A G C G G U U U C U G A G G C G C U U C C G G C A G C G A
Escherichia coli C A C C C A A A G G C U A A A C C G C U G G C G G A G U C A U C A A U C C C G U C G G A A G C A C U G A C A G C G G U U C C C C C U G A G C U U C C G G C A G U G A
Citrobacter koseri
AG C C C A A A G U C U G A A C C G U U G A C A G C A U C A G A G C C G C U G C C G G A G G C G C U G A C A A C G G A G C U A C G A U C G C A A C C G G C G G A U G
Pantoea sp. At-9b Sequence alignment of the ATP7B gene sequences in the vicinity of the slippery sequence (shaded red 
AG C C C A A A G C C U G A G C C G U U G A C A G C A G C A G A G C C G C C G C C G G A G G C G C U G A C A A C G G A G U C U U C U C C U C U U C C G G C A A C U G
Pantoea ananatis
U C C C C A A A G U C U G A A C C G U U G A C A G C A U C G G A G C C G C C G C C G G A G G C G C U G A C A A C G G A G A C C C C U U C U C A U C C G G C A G A A A
Pantoea vagans
U C C C C A A A A U C U G A G C C G C U G A C C G A U A A G G C G A G U G U U U U G C C G G A A C C C C U G U C A G C G G C U G C G U C A C C U G U U C C G G C U G A G A
Rahnella aquatilis
C C C A A A A A C U A A U C C G C U G G C A G A G U C A G A U A C C C C G U C G G A A G A G C U G A C A G C G G A G C C A C A A U C C C U U C C G
